Sanofi Holds Line On Aventis Merger Price; Novartis Enters Talks
This article was originally published in The Pink Sheet Daily
Executive Summary
Sanofi will continue to evaluate the market reaction before deciding whether to sweeten its bid. Novartis accepts Aventis’ invitation to explore a deal; the move indicates France has expressed neutrality on an Aventis/Novartis combination.